Mathew Blackman
Stock Analyst at Stifel
(3.73)
# 609
Out of 4,814 analysts
56
Total ratings
46.34%
Success rate
8.95%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mathew Blackman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLPT ClearPoint Neuro | Maintains: Buy | $19 → $25 | $12.25 | +104.08% | 3 | Apr 1, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $25 | $11.18 | +123.61% | 1 | Feb 24, 2025 | |
| PODD Insulet | Maintains: Hold | $245 → $293 | $246.95 | +18.65% | 3 | Feb 21, 2025 | |
| GMED Globus Medical | Maintains: Buy | $92 → $94 | $72.35 | +29.92% | 5 | Feb 21, 2025 | |
| OFIX Orthofix Medical | Upgrades: Buy | $18 → $24 | $13.05 | +83.91% | 5 | Nov 8, 2024 | |
| CERS Cerus | Maintains: Buy | $6 → $3 | $1.31 | +129.89% | 1 | Oct 17, 2024 | |
| PEN Penumbra | Initiates: Buy | $238 | $277.77 | -14.32% | 1 | Sep 17, 2024 | |
| DXCM DexCom | Maintains: Buy | $90 → $100 | $68.61 | +45.75% | 11 | Aug 23, 2024 | |
| ATEC Alphatec Holdings | Maintains: Buy | $19 → $16 | $10.54 | +51.87% | 5 | Aug 1, 2024 | |
| TNDM Tandem Diabetes Care | Maintains: Buy | $55 → $60 | $16.86 | +255.98% | 5 | May 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6 → $7 | $6.88 | +1.74% | 12 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $18 → $11 | $7.82 | +40.66% | 4 | May 10, 2023 |
ClearPoint Neuro
Apr 1, 2025
Maintains: Buy
Price Target: $19 → $25
Current: $12.25
Upside: +104.08%
Beta Bionics
Feb 24, 2025
Initiates: Buy
Price Target: $25
Current: $11.18
Upside: +123.61%
Insulet
Feb 21, 2025
Maintains: Hold
Price Target: $245 → $293
Current: $246.95
Upside: +18.65%
Globus Medical
Feb 21, 2025
Maintains: Buy
Price Target: $92 → $94
Current: $72.35
Upside: +29.92%
Orthofix Medical
Nov 8, 2024
Upgrades: Buy
Price Target: $18 → $24
Current: $13.05
Upside: +83.91%
Cerus
Oct 17, 2024
Maintains: Buy
Price Target: $6 → $3
Current: $1.31
Upside: +129.89%
Penumbra
Sep 17, 2024
Initiates: Buy
Price Target: $238
Current: $277.77
Upside: -14.32%
DexCom
Aug 23, 2024
Maintains: Buy
Price Target: $90 → $100
Current: $68.61
Upside: +45.75%
Alphatec Holdings
Aug 1, 2024
Maintains: Buy
Price Target: $19 → $16
Current: $10.54
Upside: +51.87%
Tandem Diabetes Care
May 29, 2024
Maintains: Buy
Price Target: $55 → $60
Current: $16.86
Upside: +255.98%
May 8, 2024
Maintains: Hold
Price Target: $6 → $7
Current: $6.88
Upside: +1.74%
May 10, 2023
Downgrades: Hold
Price Target: $18 → $11
Current: $7.82
Upside: +40.66%